Skip to main content
logo
Transgene SA (EPA:TNG)
France flag France · Delayed Price · Currency is EUR
0.7800
0.00 (0.00%)
At close: Mar 13, 2026

Transgene Revenue

Transgene had revenue of 4.58M EUR in the half year ending June 30, 2025, a decrease of -3.86%. This brings the company's revenue in the last twelve months to 7.58M, up 16.65% year-over-year. In the year 2024, Transgene had annual revenue of 6.35M, down -19.58%.

Revenue (ttm)
7.58M
Revenue Growth
+16.65%
P/S Ratio
28.20
Revenue / Employee
51.53K
Employees
147
Market Cap
213.59M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20246.35M-1.55M-19.58%
Dec 31, 20237.90M-2.44M-23.63%
Dec 31, 202210.34M-6.90M-40.00%
Dec 31, 202117.24M7.67M80.08%
Dec 31, 20209.57M-3.72M-28.00%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Valneva SE179.91M
Cellectis70.36M
Genfit45.13M
MedinCell32.44M
Adocia12.88M
Innate Pharma12.64M
Sensorion5.65M
ABIONYX Pharma4.33M
Revenue Rankings

Transgene News

More News